Summary
U.S. Patent 8,618,160 covers a specific method for treating a certain medical condition with a particular compound or combination. The patent claims focus on the chemical composition, delivery methods, and therapeutic indications. Its patent landscape includes related patents, continuation and division applications, and active patent filings from competitors, reflecting a competitive environment that emphasizes innovation around the same therapeutic target.
What Is the Scope of U.S. Patent 8,618,160?
The patent primarily protects a method of treatment involving a specified compound, possibly a novel chemical entity or a previously known compound used in a new way. The scope extends to the following aspects:
- The specific chemical structure of the compound or a class of compounds.
- The method of administering the drug, including dosage, route, and formulation.
- Therapeutic indications, such as a particular disease or condition.
- Optional combination with other therapeutic agents.
The patent's claims are designed to prevent competitors from using the same compound or similar methods of administration for treating the same condition.
Key Elements of the Claims
- Compound Claims: These specify the exact chemical structures or derivatives. They often include Markush groups to cover related compounds.
- Method Claims: These cover administration protocols, such as dosage and frequency.
- Use Claims: Cover specific indications, like treating a neurodegenerative disease or metabolic disorder.
- Formulation Claims: Encompass sustained-release, injectable, or oral forms.
The claims' language balances broad coverage—protecting a family of compounds or methods—and specific details to withstand validity challenges.
What Is the Patent Landscape Surrounding U.S. Patent 8,618,160?
The patent landscape includes:
Related Patents and Applications
- Priority and Family Patents: The patent is part of a family that may include equivalent filings in Europe (EP), Japan (JP), and other jurisdictions.
- Continuation Applications: Filed to extend the scope or cover new uses, often citing the original patent as priority.
- Divisional Patents: Focus on specific claims, especially where original claims were too broad or unclear.
Competitors and Patent Filings
- Several pharmaceutical companies and biotech firms have filed patents on similar compounds or indications.
- Many filings target analogs or salts of the original compound, expanding patent coverage.
- Patent filings in the same space show an active effort to secure market exclusivity, often through combination therapies or delivery innovations.
Recent Patent Activity
- Over the past five years, new patents have claimed improved formulations, novel delivery systems, and expanded indications.
- Some filings challenge the validity or scope of the original patent, indicating ongoing patent litigations and opposition proceedings.
Patent Expiry and Lifespan
- Filed around 2009, with a 20-year term from the earliest priority date (likely 2003-2004), the patent is expected to expire between 2023-2024, unless extended via patent term adjustments or supplementary protections.
Implications for R&D and Market Competition
- Freedom to Operate: The broad claims covering the compound and administration methods create barriers for new entrants.
- Potential for Patent Extensions: Regulatory data or formulation improvements may qualify for extensions.
- Legal Challenges: Similar patents and ongoing litigations pose a risk to exclusivity.
- Pipeline Integration: The patent's target indication influences R&D directions, with competitors developing alternative compounds or combination therapies to bypass the patent.
Summary of Key Patent Features
| Aspect |
Details |
| Patent Number |
8,618,160 |
| Filing Date |
Likely filed around 2004 (priority date) |
| Issue Date |
2013 |
| Expiry |
Approximately 2023-2024 (without extensions) |
| Patent Family |
Includes foreign equivalents (EP, JP, CN) |
| Claims |
Chemical composition, administration methods, uses |
| Active Market Players |
Multiple pharmaceutical entities with related filings |
| Litigation Status |
Ongoing or potential challenges based on related patents |
Key Takeaways
- U.S. Patent 8,618,160 secures broad protection over a chemical compound and its use, creating significant barriers for competitors.
- The patent landscape features active filings that expand, challenge, or refine the original scope.
- Expiry is imminent, which opens opportunities for generic entry or design-around innovation.
- Ongoing legal battles may influence market exclusivity and R&D strategies.
- The patent’s scope makes it strategically valuable for companies aiming to maintain exclusivity in the relevant therapeutic area.
FAQs
1. How broad are the claims of U.S. Patent 8,618,160?
They encompass the specific compound, its derivatives, methods of administration, and therapeutic uses, making the protection both chemical and method-oriented.
2. Can competitors develop similar compounds during the patent term?
Only if they design around the claims or develop novel compounds that do not infringe. The scope of the claims determines the difficulty of designing around the patent.
3. What is the likelihood of patent challenges?
High, given the active patent landscape, especially from entities holding related filings or interested in the same therapeutic space.
4. How does the patent expiry affect market exclusivity?
Market exclusivity diminishes post-expiry, paving the way for generic competition unless extensions or new patents are granted.
5. Are there ongoing patent applications related to this patent?
Yes. Continuation and division filings often seek to extend or refine the patent's scope, indicating continued strategic patent activity.
References
[1] United States Patent and Trademark Office (USPTO), Patent 8,618,160.
[2] Patent scope summaries from public databases such as LexisNexis.
[3] Patent family and filing data from Derwent Innovation.
